Oliveira Ricardo, Branco Luisa, Galrinho Ana, Abreu Ana, Abreu João, Fiarresga Antonio, Mamede Andreia, Ramos Ruben, Leal Ana, Pinto Eugénia, Fragata José, Ferreira Rui
Serviço de Cardiologia, Hospital de Santa Marta, Lisboa, Portugal.
Rev Port Cardiol. 2010 Jul-Aug;29(7-8):1087-100.
Transthoracic echocardiography is the method of choice for the diagnosis of cardiac myxomas, but the transesophageal approach provides a better definition of the location and characteristics of the tumor. The authors review their thirteen years' experience on the echocardiographic diagnosis of this pathology.
From 1994 to 2007, 41 cardiac tumors were diagnosed in our echocardiographic laboratory, of which 27 (65.85%) were cardiac myxomas. The exams and the patients' clinical files were retrospectively reviewed.
Of the 27 patients, 22 (81.5%) were female, with a mean age of 62.1 +/- 13.6 years (25-84 years). The predominant clinical features were due to the obstruction caused by the tumor in more than two thirds of the patients, followed by constitutional symptoms in one third and embolic events in 30%. In the lab results, anemia was found in three patients and elevated sedimentation rate and CRP in two. In two patients the myxoma was found by chance. All the cases were of the sporadic type, although we found a prevalence of thyroid disease of 14% (4 patients). All patients underwent urgent surgical resection except one, in whom surgery was refused due to advanced age and comorbidities. The myxomas followed a typical distribution with 24 (88.8%) located in the left atrium, 18 of them attached to the atrial septum (AS) and two to the mitral valve. In one patient, the tumor involved both atria. The other two cases originated in the right atrium at the AS. Embolic phenomena were more frequent in small tumors (p = 0.027) and in those with a villous appearance (p = 0.032). Obstructive manifestations were associated with larger tumors (p = 0.046) and larger left atria (p = 0.048). In our series, there were no deaths during hospitalization or in the follow-up period of 5.2 +/- 3.7 years in 19 patients. There were two recurrences, both patients being successfully reoperated.
Myxoma is the most common cardiac tumor. Transesophageal echocardiography provides excellent morphologic definition, aiding in diagnosis and follow-up. Most clinical manifestations are obstructive and are associated with larger tumors. Small tumors with a friable appearance have a higher chance of embolization. Surgical resection is usually curative and the long-term prognosis is excellent.
经胸超声心动图是诊断心脏黏液瘤的首选方法,但经食管途径能更好地明确肿瘤的位置和特征。作者回顾了他们13年来对这种病变进行超声心动图诊断的经验。
1994年至2007年,我们的超声心动图实验室诊断出41例心脏肿瘤,其中27例(65.85%)为心脏黏液瘤。对检查结果和患者的临床病历进行了回顾性分析。
27例患者中,22例(81.5%)为女性,平均年龄62.1±13.6岁(25 - 84岁)。超过三分之二的患者主要临床特征是由肿瘤引起的梗阻,三分之一的患者有全身症状,30%的患者有栓塞事件。实验室检查结果显示,3例患者有贫血,2例患者血沉和CRP升高。2例患者的黏液瘤是偶然发现的。所有病例均为散发性类型,不过我们发现甲状腺疾病的患病率为14%(4例患者)。除1例因年龄较大和合并多种疾病拒绝手术外,所有患者均接受了紧急手术切除。黏液瘤分布具有典型特征,24例(88.8%)位于左心房,其中18例附着于房间隔,2例附着于二尖瓣。1例患者的肿瘤累及两个心房。另外2例起源于右心房房间隔处。栓塞现象在小肿瘤(p = 0.027)和外观呈绒毛状的肿瘤中更常见(p = 0.032)。梗阻表现与较大的肿瘤(p = 0.046)和较大的左心房(p = 0.048)有关。在我们的系列研究中,19例患者在住院期间或5.2±3.7年的随访期内均无死亡。有2例复发,这两名患者均成功接受了再次手术。
黏液瘤是最常见的心脏肿瘤。经食管超声心动图能提供出色的形态学定义,有助于诊断和随访。大多数临床表现为梗阻性,且与较大的肿瘤有关。外观易碎的小肿瘤发生栓塞的几率更高。手术切除通常可治愈,长期预后良好。